Affiliation:
1. Siberian State Medical University
Abstract
The problem of cognitive dysfunction is currently of interest to doctors of various specialties, since this complication is accompanied by many systemic diseases that involve the central nervous system in the pathological process. However the diagnosis of such violations is given insufficient attention due to the lack of objective methods of verification of this diagnosis. The article presents modern ideas on the possibilities of proton magnetic resonance spectroscopy (1H-MPC) in the diagnosis of cognitive dysfunction in patients with type 1 diabetes mellitus. The role of both hypoglycemia and hyperglycemia in the formation of cognitive dysfunction is considered. The relationship between the state of carbohydrate metabolism and the disorders detected by 1H-MPC is shown.
Publisher
Medical Informational Agency Publishers
Reference35 articles.
1. Danielsen E.R., Ross B., eds. Magnetic resonance spectroscopy diagnosis of neurological disease. New York: Marcel Dekker, Inc; 1999
2. Trufanov G.E., Tjutin L.A. Magneticresonance spectroscopy. St.-Petersburg:JeLBI-SPb Publ., 2008. (in Russian).
3. Gujar S.K., Maheshwari S., Bjorkman-Burtscher I., Sundgren P.C. Magnetic Resonance Spectroscopy. J. Neuroophthalmol. 2005; 25(3): 217-26.
4. Burtscher I.M., Holtas S. Proton MR spectroscopy in clinical routine. J. Magn. Reson. Imaging. 2001; 13: 560-7.
5. Castillo M., Kwock L., Mukherji S.K. Clinical applications of proton MR spectroscopy. AJNR Am. J. Neuroradiol. 1996;17: 1-15.